Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine

NCT02937207 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2020-02-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the application in community hospitals.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Ke Chuan Liu Wei Mixture

Experience formula of famous traditional Chinese professor Yingen Wu

DRUG

Chuan Xiong Ping Chuan Mixture

Experience formula of famous traditional Chinese professor Changrong Shao

DRUG

Xie Wu Capsule

Experience formula of famous traditional Chinese professor Jianhua Hu

DRUG

Dan Ma Jia Tablet

Experience formula of famous traditional Chinese professor Xiaopu Xu

DRUG

Zhi Chuan Capsule

Experience formula of famous traditional Chinese professor Yingen Wu

DRUG

Bu Shen Na Qi Granule

Experience formula of famous traditional Chinese professor Changrong Shao

DRUG

Ke Chuan Liu Wei Mixture placebo

Low dose combination for treating prescription of Ke Chuan Liu Wei Mixture

DRUG

Chuan Xiong Ping Chuan Mixture placebo

Low dose combination for treating prescription of Chuan Xiong Ping Chuan Mixture

DRUG

Xie Wu Capsule placebo

Low dose combination for treating prescription of Xie Wu Capsule

DRUG

Dan Ma Jia Tablet placebo

Low dose combination for treating prescription of Dan Ma Jia Tablet

DRUG

Zhi Chuan Capsule placebo

Low dose combination for treating prescription of Zhi Chuan Capsule

DRUG

Bu Shen Na Qi Granule placebo

Low dose combination for treating prescription of Bu Shen Na Qi Granule

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Zhenhui Lu, Doctor · Longhua Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-30
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937207 on ClinicalTrials.gov